Dr. Jeffrey R. Jay, M.D.

Great Point Partners as of June 30, 2026

Portfolio Holdings for Great Point Partners

Great Point Partners holds 41 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Abivax Sa Sponsored Ads (ABVX) 15.2 $81M 604k 133.26
Vor Biopharma Com New (VOR) 5.9 $31M 1.7M 18.41
Immunitybio Put Option (IBRX) 5.0 $26M 3.0M 8.76
Vera Therapeutics Cl A (VERA) 4.9 $26M 601k 42.91
Zura Bio Class A Ord Shs (ZURA) 4.7 $25M 4.2M 5.90
Alumis (ALMS) 4.6 $24M 856k 28.14
Sol-gel Technologies Shs New (SLGL) 3.8 $20M 274k 74.14
Ultragenyx Pharmaceutical Put Option (RARE) 3.8 $20M 600k 33.39
Definium Therapeutics Com Shs (DFTX) 3.8 $20M 425k 47.04
Annexon (ANNX) 3.8 $20M 3.5M 5.71
Oruka Therapeutics (ORKA) 3.3 $17M 183k 95.17
Moonlake Immunotherapeutics Class A Ord (MLTX) 3.1 $17M 856k 19.47
Sagimet Biosciences Com Ser A (SGMT) 3.0 $16M 2.0M 7.73
Contineum Therapeutics Cl A (CTNM) 2.9 $15M 922k 16.39
Immix Biopharma (IMMX) 2.5 $13M 1.3M 10.31
Eliem Therapeutics (CLYM) 2.5 $13M 1.0M 13.04
Amylyx Pharmaceuticals (AMLX) 2.4 $13M 700k 17.96
Nektar Therapeutics Com New (NKTR) 2.3 $12M 175k 69.81
Neurogene (NGNE) 2.1 $11M 352k 31.45
Lb Pharmaceuticals Com Shs (LBRX) 1.9 $10M 317k 32.45
Ocuphire Pharma (IRD) 1.5 $8.1M 2.0M 4.11
Eupraxia Pharmaceuticals (EPRX) 1.5 $7.9M 1.2M 6.61
Bright Minds Biosciences Com New (DRUG) 1.5 $7.7M 110k 70.20
Inflarx Nv (IFRX) 1.3 $6.8M 3.0M 2.24
Relmada Therapeutics (RLMD) 1.1 $5.8M 842k 6.92
Jatt Ii Acquisition Corp Ord Shs 1.1 $5.7M 500k 11.36
Cullinan Oncology (CGEM) 1.0 $5.5M 300k 18.21
Altimmune Com New (ALT) 1.0 $5.3M 1.7M 3.04
Amanat Acquisition Corp Cl A Ord 1.0 $5.1M 500k 10.16
Rezolute Com New (RZLT) 0.9 $4.9M 952k 5.20
Silence Therapeutics Ads (SLN) 0.9 $4.9M 450k 10.98
Palisade Bio (PALI) 0.9 $4.8M 2.3M 2.09
Evommune Com Shs (EVMN) 0.8 $4.3M 325k 13.29
Scynexis 0.7 $3.8M 944k 4.07
Galectin Therapeutics Com New Call Option (GALT) 0.7 $3.7M 800k 4.64
Enliven Therapeutics (ELVN) 0.7 $3.6M 70k 50.75
Humacyte (HUMA) 0.6 $2.9M 3.8M 0.78
Rein Therapeutics Com New (RNTX) 0.5 $2.7M 2.6M 1.04
Dbv Technologies S A Sponsored Ads (DBVT) 0.5 $2.6M 157k 16.40
Anavex Life Sciences Corp Com New Call Option (AVXL) 0.3 $1.4M 521k 2.59
Promis Neurosciences Com Shs (PMN) 0.2 $1.1M 86k 13.16